GeneReach Biotechnology Corp. (4171.TWO) Price History & Returns
How GeneReach Biotechnology Corp. (4171.TWO) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.
The share price of $16.70 sits 6% of the way up a 52-week range of $16.05 to $26.90; 37.9% below the 52-week high; a beta of 0.38 means it has historically moved less than the market.
Total return
Price change over each trailing period, not annualised.
Year by year
5 of 14 years closed higher than the year before. Closes are the last observation in each calendar year.
Monthly closing prices
The last 36 months, newest first. 10 of 36 months closed higher than the month before. Each figure is the last close in that month.
GeneReach Biotechnology Corp. (4171.TWO) price history — frequently asked questions
How has GeneReach Biotechnology Corp. performed over the last year?
GeneReach Biotechnology Corp. (4171.TWO) has fallen 33.2% over the last twelve months, measured on price alone.
What is GeneReach Biotechnology Corp.'s five-year return?
Over five years the 4171.TWO share price has lost 67.9%, excluding dividends.
What is GeneReach Biotechnology Corp.'s 52-week range?
Over the last year GeneReach Biotechnology Corp. (4171.TWO) has traded between $16.05 and $26.90.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.